Kenya Medical Supplies Authority (K Pharmaceutical Import Profile — Kenya (DGFT 2022–2026)

Name: Kenya Medical Supplies Authority (K Pharmaceutical Import Records from India — 2 Products, $700.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kenya Medical Supplies Authority (K — Pharmaceutical Importer Profile (2026) | 2 Products, $700.0K Trade | TransData Nexus

Kenya Medical Supplies Authority (K — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

The Kenya Medical Supplies Authority (KEMSA) is a state corporation under the Ministry of Health, established under the KEMSA Act of 2013. Its primary mandate is to procure, warehouse, and distribute health products and technologies for public health programs, the national strategic stock reserve, essential health packages, and national referral hospitals. KEMSA plays a pivotal role in ensuring the availability of quality, affordable medical commodities across Kenya, thereby supporting the country's healthcare system. (kemsa.go.ke)

Headquartered in Nairobi, KEMSA operates a network of storage, packaging, and distribution facilities throughout Kenya. This extensive infrastructure enables the efficient delivery of medical supplies to health institutions nationwide. The organization serves a diverse clientele, including national and county governments, faith-based organizations, non-governmental organizations, learning institutions, and specialized institutions such as the Kenya Defense Forces and prisons. (kemsa.go.ke)

2Distribution Network

KEMSA's distribution network is robust and expansive, encompassing a central warehouse in Nairobi and multiple regional depots strategically located to serve all 47 counties in Kenya. This setup ensures timely and efficient delivery of medical supplies to health facilities across the country. The authority's logistics capabilities include modern warehousing systems with features such as racking, air conditioning, CCTV surveillance, cold-chain storage, quality assurance laboratories, and advanced mechanical handling equipment. Additionally, KEMSA operates a 24/7 Supply Chain Centre to manage and coordinate the distribution of health products and technologies. (kemsa.go.ke)

3Industry Role

KEMSA functions as the primary wholesaler and distributor of medical supplies within Kenya's pharmaceutical supply chain. By procuring, warehousing, and distributing health products and technologies, it ensures that public health facilities have access to essential medical commodities. The authority's role is critical in maintaining the efficiency and effectiveness of the healthcare supply chain, directly impacting the quality of healthcare services provided to the Kenyan population. (kemsa.go.ke)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Kenya Medical Supplies Authority (K

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

KEMSA's sourcing strategy exhibits a high degree of concentration, with a portfolio focused exclusively on finished pharmaceutical formulations imported from India. The total import value from India stands at $700,000 USD, distributed across 14 shipments. The top two products imported are Artemether ($400,000 USD) and Artesunate ($300,000 USD), both within the Antimalarial & Antiparasitic therapeutic category. This concentration indicates a strategic choice to source specific, high-demand antimalarial medications from India, leveraging the country's established pharmaceutical manufacturing capabilities.

The stability of this sourcing relationship is suggested by the consistent import values and the absence of significant fluctuations in shipment volumes. However, the lack of diversification in sourcing could pose risks related to supply chain disruptions, currency fluctuations, or changes in regulatory policies affecting imports from India. To mitigate these risks, KEMSA may consider exploring alternative suppliers or diversifying its product portfolio to ensure a more resilient supply chain.

2Supply Chain Resilience

KEMSA's supply chain resilience is closely tied to its sourcing strategy from India. The authority's reliance on a single supplier for its antimalarial medications could expose it to risks such as supply disruptions, regulatory changes, or geopolitical tensions affecting trade routes. To enhance resilience, KEMSA could consider establishing relationships with multiple suppliers, including those from other countries, to diversify its sources and reduce dependency on a single market. Additionally, expanding its product range to include other therapeutic categories could help mitigate risks associated with over-reliance on a specific product line.

Importing Pharmaceuticals into Kenya — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Kenya

1Regulatory Authority & Framework

In Kenya, the Pharmacy and Poisons Board (PPB) serves as the primary regulatory authority overseeing the importation, distribution, and sale of pharmaceutical products. The PPB is responsible for ensuring that all medical commodities meet the required safety, efficacy, and quality standards before they are permitted for use within the country. Key legislation governing pharmaceutical imports includes the Pharmacy and Poisons Act, which outlines the procedures for registration, importation, and distribution of drugs. Additionally, the Food, Drugs and Chemical Substances Act provides further regulatory guidelines to ensure public health safety.

For Indian pharmaceutical companies seeking to export to Kenya, understanding and complying with these regulatory frameworks is essential. The registration process involves submitting detailed product dossiers, including evidence of Good Manufacturing Practice (GMP) compliance, clinical trial data, and quality control measures. The PPB evaluates these submissions to ensure that imported products align with Kenya's health standards and regulatory requirements.

2Import Licensing & GMP

Import licensing in Kenya requires pharmaceutical companies to obtain approval from the Pharmacy and Poisons Board (PPB) before importing medical products. This process involves submitting an application that includes comprehensive product information, manufacturing details, and evidence of GMP compliance. The PPB recognizes GMP certifications from reputable international bodies, such as the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S), as part of the evaluation process. Additionally, wholesale distribution authorization is mandatory for entities involved in the distribution of medical supplies within Kenya. This authorization ensures that distributors adhere to the regulatory standards set forth by the PPB, maintaining the integrity and safety of the pharmaceutical supply chain.

Kenya Medical Supplies Authority (K — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

KEMSA's focus on importing antimalarial medications, specifically Artemether and Artesunate, aligns with the high prevalence of malaria in Kenya and the critical need for effective treatment options. The decision to source these products from India leverages the country's established pharmaceutical manufacturing capabilities and cost-effectiveness. This strategic sourcing ensures a steady supply of essential medications, contributing to the national effort to combat malaria and improve public health outcomes.

2Sourcing Profile

KEMSA's sourcing strategy is centered on importing generic antimalarial drugs from India, reflecting a preference for cost-effective and widely used formulations. This approach allows the authority to provide affordable treatment options to the Kenyan population, particularly in the public health sector. India's robust pharmaceutical industry, known for its adherence to international quality standards, makes it a reliable source for these essential medications.

3Market Positioning

By focusing on the importation of antimalarial medications, KEMSA positions itself as a key supplier to public health facilities, national referral hospitals, and other government health programs. This strategic focus enables the authority to meet the specific needs of these institutions, ensuring the availability of essential treatments for malaria. KEMSA's role is crucial in supporting the government's efforts to provide comprehensive healthcare services to the Kenyan population.

Seller's Guide — How to Become a Supplier to Kenya Medical Supplies Authority (K

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

The concentrated sourcing pattern of KEMSA presents opportunities for new Indian suppliers to enter the Kenyan market by offering alternative antimalarial medications or expanding into other therapeutic categories. Diversifying the product portfolio could help KEMSA mitigate risks associated with over-reliance on a single product line and enhance the resilience of its supply chain. For Indian exporters, establishing partnerships with KEMSA could lead to long-term collaborations, provided they meet the regulatory requirements and quality standards set by the Pharmacy and Poisons Board.

2Requirements & Qualifications

Indian exporters aiming to supply pharmaceutical products to KEMSA must ensure that their products are registered with the Pharmacy and Poisons Board (PPB) in Kenya. This involves submitting comprehensive product dossiers, including evidence of Good Manufacturing Practice (GMP) compliance, clinical trial data,

TransData Nexus Research · Industry procurement practicesMar 2026

Frequently Asked Questions — Kenya Medical Supplies Authority (K

What products does Kenya Medical Supplies Authority (K import from India?

Kenya Medical Supplies Authority (K imports 2 pharmaceutical products across 1 categories. Top imports: Artemether ($400.0K), Artesunate ($300.0K).

What is Kenya Medical Supplies Authority (K's total pharmaceutical import value?

Kenya Medical Supplies Authority (K's total pharmaceutical import value from India is $700.0K, based on 14 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Kenya Medical Supplies Authority (K focus on?

Kenya Medical Supplies Authority (K imports across 1 categories. The largest: Antimalarial & Antiparasitic (100.0%).

Get Full Kenya Medical Supplies Authority (K Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

#	Product	Category	Value	Ships	Share	Rk
1	Artemether	Antimalarial & Antiparasitic	$400.0K	8	0.0%	1
2	Artesunate	Antimalarial & Antiparasitic	$300.0K	6	0.2%	15

Kenya Medical Supplies Authority (K

Kenya Medical Supplies Authority (K — Import Portfolio & Supplier Network

What Products Does Kenya Medical Supplies Authority (K Import?

Top Products by Import Value

Kenya Medical Supplies Authority (K Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Related Trade Data

Need Detailed Data?